Status not kept up to date
Evaluation of Efficacy and Tolerance of JOE on 4 to 11 Years Old Asthmatic Patients of GINA 2,3,4 and 5 Grades
NCT04942639 · Ludocare SAS · Updated 29 Feb 2024
- What is being tested
- JOE
- For
- Asthma in Children
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages 4 years to 11 years. About 213 people. The full rules are on the registry page.
- Where
- France (13 sites)
- When
- Starts or started 18 Oct 2022, ends Dec 2024. Registered 28 June 2021.
- Results
- None posted yet.
In the researchers' words
The main objective of this study is to evaluate efficacy and safety of patient's learning in self-taking of prescribed asthma maintenance treatments and provided by JOE (a new DTX), on the number of severe exacerbations in children with an asthma graded 2, 3, 4 and 5 according to GINA classification.
Sites
- Cabinet de pneumologie pédiatrique La FouraneAix-en-Provence, France
- CHU AmiensAmiens, France
- APHP - Hôpital Ambroise ParéBoulogne-Billancourt, France
- CHRU MorvanBrest, France
- CHU CaenCaen, France
- CHU Clermont-FerrandClermont-Ferrand, France
- CHI CréteilCréteil, France
- Groupe Hospitalier du HavreLe Havre, France
- CH Saint JosephMarseille, France
- Cabinet MedeoMontluçon, France
- Hôpital Arnaud de VilleneuveMontpellier, France
- APHP - Hôpital Armand TrousseauParis, France
- APHP - Hôpital Robert DebréParis, France